Showing results (181-190 of 194) with videos related to
Sort By:
Pageof 20
Cureus|August 30, 2022
Drug-Induced Hyperthermia ReviewMichael Horseman, Ladan Panahi, George Udeani, et al.The New England Journal of Medicine|September 19, 2003
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unitDeborah Cook, Graeme Rocker, John Marshall, et al.Future Microbiology|September 2, 2022
Evaluation of the potential of Rejuveinix plus dexamethasone against sepsisFatih M Uckun, Muhammad Saeed, Mustafa Awili, et al.Circulation|May 12, 2010
Acute kidney injury and cardiovascular outcomes in acute severe hypertensionLynda A Szczech, Christopher B Granger, Joseph F Dasta, et al.Anesthesiology|November 25, 2015
Platelet Counts, Acute Kidney Injury, and Mortality after Coronary Artery Bypass Grafting SurgeryMiklos D Kertai, Shan Zhou, Jörn A Karhausen, et al.World Journal of Critical Care Medicine|June 25, 2020
Critical care practice in India: Results of the intensive care unit need assessment survey (ININ2018)Rahul Kashyap, Kirtivardhan Vashistha, Chetan Saini, et al.Critical Care Medicine|June 14, 2011
Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension registryStephan A Mayer, Pedro Kurtz, Allison Wyman, et al.BMJ Open|March 29, 2013
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trialChad M Cannon, Phillip Levy, Brigitte M Baumann, et al.Critical Care (London, England)|June 29, 2011
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency departmentW Frank Peacock, Joseph Varon, Brigitte M Baumann, et al.Postgraduate Medicine|August 21, 2014
The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine?Joseph Varon, Karina M Soto-Ruiz, Brigitte M Baumann, et al.Pageof 20